Melanoma Research Victoria (MRV) is an award-winning collaborative research program that engages with all stakeholders, including patients; carers; researchers; clinicians; government; and industry, to improve outcomes for melanoma patients. Its multi-faceted organisation includes six key components: 

• Clinical cohort recruited from five key Victorian melanoma clinics; 
• Clinical data and biospecimens generously donated by the cohort participants; 
• Governance Committee and Administrative staff; 
• Consumer Reference Group (CRG); 
• Clinical and non-clinical researchers conducting quality collaborative research locally, nationally and internationally; 
• Collaborative relationships with the wider melanoma community, the public, pharmaceutical companies and government.